In vivo responses to interferon (IFN) in mice were determined by measuring the steady-state levels of induced mRNAs following injection of IFN and poly(I)-poly(C). With cDNA probes for mouse 2'-5' oligoadenylate synthetase (2-5A synthetase) and 1-8, constitutive expression of the corresponding mRNA was detectable in different organs of normal C3H/He mice. These mRNA levels were increased by as much as 15-fold over control levels in various tissues, including the brain, after IFN and poly(I)-poly(C) treatment, coincident with increases in 2-5A synthetase enzyme activity. The basal activity level of this enzyme could be reduced in normal mice by treatment with anti-mouse IFN (a+|(B) antibody. This treatment also reduced the levels of 2-5A synthetase and 1-8 mRNAs. Thus, physiological levels of circulating IFN maintain elevated levels of IFN-induced mRNAs in mice. Furthermore, changes in 2-5A synthetase enzyme activity reflect the changes in gene expression in vivo.
The biological activity of interferons (IFN) in cell culture is mediated largely by induction of a number of novel proteins. Whereas many of these proteins have not been characterized in detail, the enzyme 2'-5' oligoadenylate (2-5A) synthetase, has been used as an indicator of interferon activity both in vitro and in vivo (see reference 23 for a review). This IFN-induced enzyme, when activated by double-stranded RNA (dsRNA), polymerizes ATP into 2'-5'-linked oligomers which activate a latent endoribonuclease responsible for degradation of viral and cellular RNAs (5) . Low basal levels of 2-5A synthetase activity are detectable in different organs of mice, and this level is enhanced severalfold by injection of IFN or inducers of IFN, such as a virus and the synthetic dsRNA poly(I)-poly(C) (10, 12, 14, 17, 24) . When normal mice are injected with anti-mouse IFN (ot+>) antibody, the basal levels of 2-5A synthetase activity are reduced severalfold compared with those of nontreated animals (7, 8) . This result indicates that physiological levels of 2-5A synthetase activity in mice are due, at least in part, to low levels of circulating IFN (ot+p). The level of IFN is generally too low to be detected in the sera of normal mice (7) , possibly because circulating IFN has a very short half-life in vivo (2) . The physiological role of IFN produced continuously in normal mice is unclear; however, it is possible that it is functional in different processes, such as growth and differentiation, and in mediating an antiviral activity expressed in healthy animals.
The objective of this study was to determine whether the above-mentioned changes in 2-5A synthetase enzyme activity are the result of specific changes in gene expression in vivo. in transcriptional induction of a number of mRNAs (19) , including that for 2-5A synthetase (1, 21) , and a family of transcripts of unknown function, called 1-8, isolated and characterized by Friedman and co-workers (6) . Using transcription run-on assays, Hannigan and Williams (9) have * Corresponding author.
shown that the increase in the rate of transcription of both 2-5A synthetase and 1-8 mRNAs and their subsequent transcriptional down regulation closely follow the binding to and down-regulation of cell surface-localized IFN receptors. The murine bone marrow cell line JLSV-9 also responds to IFN with an increase in transcription of 2-5A synthetase (20) and 1-8 mRNAs (unpublished data). To address the question of in vivo responses to IFN at the level of gene expression, we cloned cDNAs of murine 2-SA synthetase and 1-8, which enabled us to examine the steady-state levels of these mRNAs after intravenous injection of IFN and poly(I)-poly(C) in normal C3H/He mice. Constitutive expression of 2-SA synthetase and 1-8 mRNAs was detectable in different organs of normal C3H/He mice. These basal levels were greatly increased after IFN and poly(I)-poly(C) treatment, as were the levels of 2-SA synthetase enzyme activity. Thus, the changes in enzyme activity reflect the changes in gene expression in vivo. Accordingly, mRNA levels of 2-5A synthetase and 1-8, in Isolation of IFN-induced mouse-specific clones for 1-8 and 2-5A synthetase. Mouse 2-5A synthetase and 1-8 cDNAs were isolated from a Xgtll cDNA library constructed from IFN-treated mouse JLSV-9 cells (C. Dieffenbach, H. Jacobsen, and R. Silverman, unpublished data). Human 2-5A synthetase 6-2 cDNA (21) was nick translated and used as the probe to isolate cDNAs for murine 2-SA synthetase. A number of overlapping cDNA clones were obtained and sequenced to reveal the homology between the human and murine cDNAs. The 3' region of murine cDNA clone J-2 (20) has 67% nucleic acid sequence homology with human exons 4 and 5 present in the 3' region of human cDNA 6-2. For the studies described here, two probes derived from the cDNA clone J-2 were prepared as follows. (i) A nick-translated murine 2-SA synthetase probe was prepared from a 331-base-pair (bp) fragment of cDNA J-2 which is homologous to human exon 4. The 3' terminus corresponds to nucleotide 936, and the 5' terminus is 78 bp upstream of nucleotide 693, as described by Ichii and co-workers (15) . Further analysis of several murine cDNAs indicated that this 78-bp region represents part of the intron which lies upstream of the murine exon homologous to human exon 4. (ii) An RNA probe for murine 2-SA synthetase was prepared from cDNA J-2, which had been cloned in the reverse orientation into plasmid pSP65. With SP6 polymerase, an antisense probe was prepared which included 708 bp of the 3' end of cDNA J-2, corresponding to nucleotides 693 to 1401, as described by Ichii and co-workers (15) .
Mouse 1-8 cDNA was isolated by using human 1-8 cDNA as described by Friedman and co-workers (6 x 108 National Institutes of Health U/mg of protein) and sacrificed at 2, 5, 10, or 24 h post-IFN injection. Control mice were sacrificed at the time of IFN administration as represented by time zero. The 2-5A synthetase activity in the lungs was measured after partial purification on poly(I)-poly(C)-Sepharose. Each value represents the mean of three independent assays. be visualized by Northern blot hybridization (Fig. 1 ). The increase in the level of expression of 2-5A synthetase mRNA was quantitated by slot blot hybridization followed by densitometry. The arbitrary densitometer numbers were modified such that the control message levels were normalized to 100. All experimental levels may be easily interpreted as x-fold increases or decreases over the control levels. The level of the 2-5A synthetase message in the spleen increased by 13-fold over the control level, peaking at 2 h postinjection, the earliest time point examined. At 24 h after IFN treatment, 2-5A synthetase mRNA levels remained at a level fourfold above the control level (Fig. 2) . Mouse 1-8 cDNA hybridized to a family of mRNAs ranging in size from 800 to 900 bp (Fig. 1) . In spleen tissue, 1-8 mRNA was induced sevenfold at 5 h post-IFN. This induction slowly fell to threefold above the control level at 24 h post-IFN injection (Fig. 2) . In contrast to the 2-5A synthetase and 1-8 mRNAs, the two control mRNAs, actin and mouse catalase (the gift of Robert G. Korneluk), varied little ( Fig. 1 and 2 ). Whereas actin mRNA levels increased by 2-fold after IFN injection, this increase was small compared with the 13-fold and 7-fold increases of 2-5A synthetase and 1-8 mRNAs, respectively. IFN mRNA levels did not fluctuate from basal levels throughout the 24-h time course (Fig. 2) .
Increased 2-5A synthetase and 1-8 mRNA levels after poly(I)-poly(C) injection. Poly(I)-poly(C), a synthetic, dsRNA analog, has been shown to increase circulating levels of IFN (10, 12) . Induction of the IFN message is very difficult to measure, since the message has a very short half-life (18) . In this study, there was no detectable increase in hybridization of the IFN cDNA probe at 4 and 15 h after poly(I)-poly(C) injection (Fig. 3) . However, the steady-state levels of IFN-induced 2-5A synthetase and 1-8 mRNAs were elevated at both 4 of both control and IFN-treated groups was low for brain and spleen tissues (Table 2) . Thus, mRNA levels were measured in pooled samples by using the sample sizes indicated in the figure legends. Responses to poly(I)-poly(C) treatment were similar when measured in individual samples (Table 2) or pooled samples (Fig. 3) .
In liver tissue, levels of 2-5A synthetase and 1-8 mRNAs increased two-to threefold over control levels after 4 h and fourfold over control levels at 15 h after poly(I)-poly(C) treatment (Fig. 3A) . In the spleen, 2-5A synthetase mRNA reached a level 15-fold higher in animals sacrificed at 4 h posttreatment and remained at a level 13-fold above control levels at 15-h after poly(I)-poly(C) injection. The levels of 1-8 mRNA increased to 8-and 11-fold above control levels at 4 and 15 h, respectively, postinjection (Fig. 3B) . In brain tissue, there was a dramatic difference in the magnitudes of the relative responses to poly(I)-poly(C) injection between 2-5A synthetase and 1-8 mRNAs. The level of 2-5A synthetase mRNA increased to a maximum of twofold above control levels at 15 h after poly(I)-poly(C) injection. On the other hand, 1-8 mRNA levels increased by 7-fold after 5 h and 14-fold after 15 h (Fig. 3C) . In all tissues, the levels of the control mRNAs did not fluctuate significantly, except for the catalase level in the liver tissue (Fig.  3) . At 15 h after poly(I)-poly(C) injection, there was a fourfold decrease compared with control catalase mRNA levels (Fig. 3A) .
Activity of 2-SA synthetase was also measured in individual lungs from five control mice and five mice sacrificed at 15 h after poly(I)-poly(C) injection. Activity of 2-SA synthetase increased from 14 Total RNA was prepared from frozen spleen and brain tissues as described in Materials and Methods. Individual 10 p.g samples of total RNA were slotted onto a nitrocellulose membrane and the membrane was hybridized to nick-translated mouse 1-8 cDNA. The same membrane was stripped and rehybridized to nick-translated ,-actin cDNA. The levels of 1-8 and actin mRNAs were determined by densitometry. The densitometer units were modified such that control levels were normalized to 100 ± the standard deviation. ( Table 3 ). Injection of anti-mouse IFN (a+1) antibody had little effect on levels of 2-5A synthetase activity in thymus and brain, two tissues in which control animals have low basal levels (Table 3) . To determine whether injection of anti-mouse IFN (a+>3) antibodies would also decrease levels of the IFN-induced 2-5A synthetase and 1-8 mRNAs, the levels of these two messages were quantitated by slot blot hybridization and densitometry in antibody-treated animals and compared with the levels in corresponding control animals. Initially, the levels of 1-8 and actin were measured in individual brain and spleen samples to determine the variation in signal intensity between samples. Standard errors remained within +22% (Table 4) ; therefore, mRNA levels were analyzed in pooled total RNA samples. Anti-mouse IFN (a+ >) antibody treatment had no detectable effect on the hybridization level of the IFN cDNA probe in brains, spleens, livers, or lungs (Fig. 4) . In fact, antibody treatment had little overall effect on brain tissue, since the message level of neither 2-5A synthetase nor 1-8 showed a significant decrease compared with control levels (Fig. 4A ). This might reflect the inability of anti-IFN antibodies to cross the blood-brain barrier. However, these antibodies are active elsewhere, since in the spleens of treated mice, 2-5A synthetase mRNA levels dropped by five-to sixfold and the level of 1-8 mRNA decreased by twofold compared with control mice (Fig. 4B) . The levels of both 2-5A synthetase and 1-8 mRNA in experimental livers decreased by approximately twofold below that of the control livers (Fig. 4C) . In The levels of 1-8 and actin mRNAs were determined by densitometry. The densitometer units were modified such that control levels were normalized to 100 ± the standard deviation. the lung tissues of antibody-treated animals, 2-SA synthetase mRNA levels dropped by twofold; however, the levels of 1-8 mRNA were not significantly reduced (Fig. 4D) . The levels of the control RNAs, actin and catalase, did not vary by more than 25% in any of the tissues examined (Fig. 4) .
DISCUSSION
Transcription of some IFN genes has recently been demonstrated in different humantora on of normal individuals (22 Fig. 1 and 2) . In contrast, steady-state 1-8 mRNA levels did not peak until 5 h post-IFN injection ( Fig.  1 and 2) . The difference in mRNA accumulation of 2-5A synthetase and 1-8 mRNAs was probably due to differences in posttranscriptional processing, since Hannigan and Williams (9) have shown that both messages have similar rates of synthesis after IFN treatment in vitro. Increased levels of 2-5A synthetase and 1-8 mRNAs post-IFN (Fig. 2) were detected much earlier than the increase in 2-5A synthetase enzyme activity in the lung tissues of the same mice (Table  1) . Also, 2-5A synthetase mRNA levels in spleen tissues increased by 13-fold above control mRNA levels, while in lung tissues enzyme levels increased by only 2-fold. Hence, it is possible that measurement of levels of IFN-induced mRNAs is an earlier and more sensitive indicator of IFN action in vivo.
Mice were next treated with poly(I)-poly(C), a known in vivo inducer of IFN (10, 12) . IFN mRNA levels did not differ from control levels at 4 or 15 h after poly(I)-poly(C) injection in spleen, brain, or liver tissues (Fig. 3) . However, only mouse IFN-(31 mRNA levels were measured in this study. It is also possible that any increase in IFN mRNA levels due to poly(I)-poly(C) treatment occurred before the 4-h time point. Although no increase in IFN mRNA levels was detected, poly(I)-poly(C) injection did result in induction of both 2-5A synthetase and 1-8 mRNA levels in spleen, liver, and brain tissues (Fig. 3 ). An increase in 2-SA synthetase enzyme activity was also measured in lung tissues from poly(I)-poly(C)-treated animals. The increase in 2-5A synthetase and 1-8 mRNAs in the brain (Fig. 3C ) is interesting and indicates that either the systemically introduced poly(I)-poly(C) or the induced IFN was not excluded from reaching brain tissue. Levels of 2-SA synthetase mRNA in the brain increased by 2-fold at 15 h post-poly(I)-poly(C) treatment, whereas 1-8 mRNA levels were induced to almost 14-fold over the control levels (Fig. 3C) . The difference between the magnitudes of response of 2-5A synthetase and 1-8 mRNAs found in the brain may be related to the fact that IFNresponsive human 1-8 cDNA was originally isolated from a glioblastoma cell line, T98G (6) . Although constitutive expression has been found in all mouse tissues examined, the difference in the responses of brain tissue to IFN may reflect some tissue specificity with respect to the unknown function of the 1-8 gene.
The levels of 2-5A synthetase enzyme activity and 2-5A synthetase and 1-8 mRNAs were measured in mice treated with anti-mouse IFN (oa+,1) antibody. The decrease in 2-5A synthetase mRNA corresponded well to the decrease in 2-SA synthetase enzyme activity as measured in the different organs. For example, levels of 2-5A synthetase mRNA (Fig.  4A ) and enzyme activity (Table 3 ) in brain tissues were not affected by the antibody treatment. On the other hand, 2-5A synthetase mRNA levels decreased by fivefold in spleens (Fig. 4B) , as did the enzyme activity, which decreased fourto fivefold below control levels (Table 3) . A twofold decrease in 2-5A synthetase mRNA levels was detected in both liver (Fig. 4C) and lung (Fig. 4D) tissues after antibody treatment, and a similar decrease was measured in 2-5A synthetase enzyme activity (Table 3) . Consequently, it is evident that changes in enzyme activity in vivo are the result of specific changes in gene expression in response to levels of circulating IFN. In general, 1-8 mRNA levels were not as sensitive to anti-mouse IFN (cx+,B) antibody treatment. However, 1-8 mRNA levels did decrease by twofold compared with control levels in both spleen and liver tissues (Fig. 4) . The reduction of IFN-responsive 2-5A synthetase and 1-8 mRNA levels in the organs of normal mice treated with anti-mouse IFN (a+,B) antibody provides direct evidence that circulating levels of IFN are present and active under normal physiological conditions.
